Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.3B | 5.2B | 5.6B | 4.9B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 300M | 385M | 299M | 301M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 80M | 86M | 78M | 72M |
Other income expense | 88M | 147M | 150M | 147M |
Pretax income | 369M | 225M | 214M | 269M |
Tax provision | 81M | 75M | 56M | 65M |
Net income | 288M | 150M | 158M | 204M |
Basic EPS | 4.3 | 2.3 | 2.4 | 3.1 |
Diluted EPS | 4.3 | 2.2 | 2.3 | 3.0 |
Basic average shares | 66.0M | 65.9M | 65.9M | 65.8M |
Diluted average shares | 66.9M | 67.0M | 66.8M | 66.7M |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -2M | -2M | -2M | -1M |
Preferred stock dividends | — | — | — | — |